|1.||Young, Neal S: 13 articles (10/2015 - 02/2002)|
|2.||Alter, Blanche P: 11 articles (10/2015 - 01/2005)|
|3.||Savage, Sharon A: 6 articles (02/2015 - 03/2010)|
|4.||Giri, Neelam: 6 articles (02/2015 - 03/2010)|
|5.||Bagby, Grover C: 5 articles (01/2015 - 01/2004)|
|6.||Ozawa, Keiya: 4 articles (07/2012 - 03/2008)|
|7.||Calado, Rodrigo T: 4 articles (03/2012 - 03/2005)|
|8.||Maciejewski, J P: 4 articles (06/2011 - 02/2001)|
|9.||Liu, Johnson M: 4 articles (01/2010 - 05/2003)|
|10.||Maciejewski, Jaroslaw P: 4 articles (01/2007 - 11/2003)|
|1.||Aplastic Anemia (Anemia, Hypoplastic)
04/01/2015 - "Pediatric acquired aplastic anemia (AA) is a bone marrow disorder that is difficult to distinguish from inherited bone marrow failure syndromes and hypocellular refractory cytopenia of childhood (RCC). "
06/01/2014 - "Inherited bone marrow failure syndromes (IBMFS) and acquired aplastic anemia (AA) are life-threatening marrow failure disorders. "
01/01/2012 - "Immunosuppression is a key treatment strategy for patients suffering from aplastic anemia or related immune-mediated bone marrow failure syndromes. "
01/01/2011 - "From 10 to 20% of acquired aplastic anemia survivors will develop clonal evolution within the decade following their diagnosis as will 40% of patients with some of the inherited bone marrow failure syndromes. "
07/01/2008 - "The hematologic phenotype, however, was similar to the classified inherited bone marrow failure syndromes and included single- or multiple-lineage cytopenia, severe aplastic anemia, myelodysplasia, and malignancy. "
|2.||Fanconi Anemia (Fanconi's Anemia)
07/01/2015 - "Overall, our data indicate that SRT3025 or related compounds may be beneficial in Fanconi anemia and other bone marrow failure syndromes. "
12/01/2014 - "Fanconi anemia (FA) is the most common of the inherited bone marrow failure syndromes with an incidence of approximately 1/100,000 to 1/200,000 live births. "
08/07/2014 - "These contradictory clinical manifestations are reminiscent of human inherited bone marrow failure syndromes such as Fanconi anemia (FA), caused by defective DNA repair. "
01/01/2011 - "Fanconi Anemia (FA) is the most common representative of inherited bone marrow failure syndromes (IBMFS) with a leukemic propensity. "
09/01/2006 - "Fanconi anemia (FA) is the most frequently reported of the rare inherited bone marrow failure syndromes. "
|3.||Hematologic Neoplasms (Hematological Malignancy)
03/01/2015 - "All patients were having either hematological malignancies or bone marrow failure syndromes. "
01/01/2014 - "Hematopoietic stem cell transplantation (HSCT) is widely used as a potentially curative treatment for patients with various hematological malignancies, bone marrow failure syndromes, and congenital immune deficiencies. "
03/01/1997 - "Bone marrow transplantation (BMT) has been established as a life-saving procedure in hematologic malignancies and bone marrow failure syndromes, and it may be valuable in other types of neoplastic disease. "
04/14/2011 - "A comprehensive understanding of the genes and pathways regulating hematopoiesis is needed to identify genes causally related to bone marrow failure syndromes, myelodysplastic syndromes, and hematopoietic neoplasms. "
01/01/2015 - "Allogeneic hematopoietic cell transplantation (allo-HCT), a treatment option in hematologic malignancies and bone marrow failure syndromes, is frequently complicated by Graft-versus-host disease (GVHD). "
07/01/2008 - "Emerging clinical data indicate that transfusion-dependent patients with bone marrow-failure syndromes (BMFS) are at risk of the consequences of iron overload, including progressive damage to hepatic, endocrine, and cardiac organs. "
07/01/2008 - "In this review, we will discuss the current status of iron overload in transfusion-dependent patients, and the development of Japanese guidelines for the treatment of iron overload in Japan, which were established by the National Research Group on Idiopathic Bone Marrow Failure Syndromes in Japan."
07/01/2008 - "Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes."
04/01/2012 - "When should iron chelation therapy be considered in patients with myelodysplasia and other bone marrow failure syndromes with iron overload?"
03/01/2008 - "Oral iron chelator(deferasirox) developed for the treatment of transfusional iron overload is also very useful for the management of patients with bone marrow failure syndromes."
|5.||Inborn Errors Metabolism (Inborn Errors of Metabolism)
04/17/2006 - "Haematopoietic stem cell transplantation is an accepted curative therapy for many cancers and inherited non-malignant diseases, including bone marrow failure syndromes, haemoglobinopathies, and inborn errors of metabolism. "
08/01/2014 - "A wide variety of hematologic malignancies, autoimmune diseases, inborn errors of metabolism, and bone marrow failure syndromes maybe put into a remission or potentially cured by hematopoietic stem cell transplantation (HSCT). "
01/01/2000 - "HLA-identical bone marrow or stem cell transplantation from a sibling is the preferred treatment for patients with chronic myelogenous leukemia, bone marrow failure syndromes, relapsed acute leukemia, and specific inborn errors of metabolism. "
|5.||Telomerase (Telomerase Reverse Transcriptase)
|8.||Severe congenital neutropenia
|10.||Intercellular Signaling Peptides and Proteins (Growth Factors)
|1.||Hematopoietic Stem Cell Transplantation
|2.||Drug Therapy (Chemotherapy)
|3.||Transplantation (Transplant Recipients)
|4.||Bone Marrow Transplantation (Transplantation, Bone Marrow)
|5.||Stem Cell Transplantation